Emergent BioSolutions Inc.EBSNYSE
Loading
Net Margin Over TimeExpanding
Percentile Rank29
5Y CAGR-18.2%
Studio
Year-over-Year Change

Net income as a percentage of revenue

5Y CAGR
-18.2%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM7.08%+138.8%
2024-18.26%+74.8%
2023-72.48%-282.8%
2022-18.94%-253.0%
202112.38%-36.2%
202019.39%+293.4%
20194.93%-38.5%
20188.01%-45.6%
201714.73%+39.0%
201610.60%-